Narcan
Product Images NDC 67296-1587

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Narcan (NDC 67296-1587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Narcan 01)

Chemical structure of the active ingredient in Narcan (naloxone hydrochloride), depicting a complex ring system with hydroxyl groups and an attached hydrochloride (HCl) moiety.*

FDA Label Image

Figure 1(a) (Narcan 02)

A pharmacokinetic line graph showing naloxone plasma concentration (mg/mL) over time (hours postdose) for different dosing regimens, including nasal sprays and intramuscular injection. The graph compares multiple naloxone doses with error bars indicating variability at each time point.*

FDA Label Image

Figure 1(b) (Narcan 03)

A line graph showing naloxone plasma concentration (ng/mL) over time (hours postdose) for different naloxone doses and administration methods. The graph compares concentrations for 2 mg, 4 mg, and 8 mg single sprays at varying concentrations and nostril applications, as well as a 0.4 mg intramuscular injection, illustrating pharmacokinetic differences among these treatments.*

FDA Label Image

Figure (Narcan 04)

An instructional black-and-white illustration showing hands opening the foil pouch packaging of Narcan Nasal Spray, a product by RedPharm Drug. The image demonstrates the step to peel back the foil to access the nasal spray device inside.*

FDA Label Image

Figure (Narcan 05)

An instructional illustration showing a hand holding a Narcan nasal spray device, identifying the nozzle and plunger parts for correct usage.*

FDA Label Image

Figure (Narcan 06)

An instructional black and white illustration showing a person administering nasal spray medication into the nostril of another individual lying down. The image depicts the hand positioning and nasal spray use technique.*

FDA Label Image

Figure (Narcan 07)

An illustration showing a person administering Narcan nasal spray by inserting the nozzle into a nostril and pressing the device to release the medication.*

FDA Label Image

Figure (Narcan 08)

An instructional illustration showing a person lying on their side in the recovery position. The figure demonstrates proper positioning with the hand supporting the head and the knee preventing the body from rolling onto the stomach.*

FDA Label Image

Narcan (naloxone HCl) Nasal Spray 2 mg Carton Label (Narcan 09)

Narcan nasal spray 2 mg packaging label by RedPharm Drug. The box indicates use as a 0.1 mL intranasal spray with four 2 mg doses per pack. The label includes opioid overdose response instructions, storage conditions, and usage warnings emphasizing nasal use only. The product NDC 67296-1587 is shown, with manufacturer and lot/expiration placeholders.*

FDA Label Image

Narcan (naloxone HCl) Nasal Spray 4 mg Carton Label (Narcan 10)

Narcan nasal spray 4 mg packaging label showing a two-pack box of naloxone hydrochloride nasal spray intranasal doses. The label includes instructions for use, warnings about opioid overdose, dosage information, and distributor Emergent Biosolutions. It features step-by-step illustrated administration guidance and storage conditions, with prominent branding by Narcan and a red star logo.*

FDA Label Image

Narcan (naloxone HCl) Nasal Spray 4 mg Vial Label (Narcan 11)

Label for Narcan (naloxone HCl) Nasal Spray 4 mg, indicated for use in the nose only. The label includes directions, storage instructions, and warnings. It shows the NDC 69547-353-02 and identifies the distributor as Emergent Devices Inc. The label also instructs to see an enclosed quick start guide and not to test the device before use.*

FDA Label Image

Narcan (naloxone HCl) Nasal Spray Quick Start Guide (Narcan 12)

Quick Start Guide for Narcan (naloxone HCl) Nasal Spray provides opioid overdose response instructions including identifying an opioid overdose, administering the nasal spray, and calling for emergency medical help. Illustrated steps show how to check the person, hold and insert the spray, give the dose, and place the person in the recovery position.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.